<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02450227</url>
  </required_header>
  <id_info>
    <org_study_id>M220</org_study_id>
    <secondary_id>H-3-2014-112/46407</secondary_id>
    <nct_id>NCT02450227</nct_id>
  </id_info>
  <brief_title>Carotenoid Absorption and Metabolism From Green-leafy Vegetable Matrices</brief_title>
  <acronym>Popeye</acronym>
  <official_title>Carotenoid Absorption and Metabolism From Green-leafy Vegetable Matrices - a Explorative Study in Short-bowel Patients and Healthy Controls - The &quot;Popeye-study&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Agroscope Liebefeld-Posieux Research Station ALP</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Herta Messerli Stiftung</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Glostrup University Hospital, Copenhagen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Copenhagen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Absorption and metabolism of carotenoids from two types of spinach preparations will be
      investigated in two study groups, short bowel/ileostomy and healthy, respectively.

      The study will be conducted as a randomised, controlled, 2-way crossover study in 24
      participants (12 in each group), randomized to two sequences (1-2, 2-1) of interventions with
      a more and a less bio-accessible spinach preparation. The serum, chylomicron and
      fecal/effluent levels of lutein and beta-carotene will be determined.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Absorption and metabolism of carotenoids from two types of spinach preparations will be
      investigated in two study groups, short bowel/ileostomy and healthy, respectively.

      The study will be conducted as a randomised, controlled, 2-way crossover study. Twenty four
      participants (12 in each group) will be randomized to two sequences (1-2, 2-1) of
      interventions with a more and a less bio-accessible spinach preparation (differentiates only
      on the basis of particle size).

      The intervention period is sub-divided into three parts: run-in period (48 hours) with a
      standardized low-carotenoid diet, 0-24 hours (follow-up period 1 (FP1)) and 24 hours - 2
      weeks (FP2). The intervention periods will be separated by a wash-out period of at least 14
      days.

      At start of each intervention, the intervention meal (breakfast) is served, followed by
      standardized, carotenoid-free meals in the following 24 hours. Participants will in FP1 and
      FP2 receive an intervention meal every second day. Participants will otherwise keep their
      habitual diets during these follow-up periods.

      Study participants are asked to collect urine during 24 hours before and after the first
      intervention meal in each period. They will also collect feces/ileostomy efflux for 24 hours
      before and after initiation of the intervention for short bowel/ileostomy patients and for 48
      periods in the healthy volunteers, respectively. Overnight-fasting serum samples are drawn at
      day 1, 7 and 15 of each intervention period. On day 1 plasma samples are drawn at 0,1, 3, 4,
      6, 7, 9 and 24 hours post first intervention meal.

      Plasma and effluent levels of lutein and beta-carotene will be determined and chylomicrons
      are also separated from these samples for determination of carotenoids.

      Volunteers also have their macula examined for density of the yellow spot before and after
      the intervention. Plasma and effluent levels of other carotenoids as well as fat-soluble
      vitamins are also determined. The samples will also be subjected to metabolic profiling for
      further exploration and hypothesis generation.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    It is considered non-achievable to recruit the target number of subjects in the short bowel
    group (n = 12). 10 participants were recruited.
  </why_stopped>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum concentration of lutein and beta-carotene</measure>
    <time_frame>15 days</time_frame>
    <description>Difference in serum concentration of lutein and beta-carotene between baseline and the end of each intervention period.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Concentration of lutein and beta-carotene in the chylomicron/TLR fraction</measure>
    <time_frame>24 hours</time_frame>
    <description>Changes in concentration of lutein and beta-carotene in the chylomicron/TLR fraction (area under the curve, AUC) 24 hours post first intervention meal in each intervention periods.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total lutein and beta-carotene sekretion with feces/ileostomy-efflux</measure>
    <time_frame>48/24 hours</time_frame>
    <description>Total lutein and beta-carotene sekretion with feces/ileostomy-efflux 48 and 24 hours postprandial, for healthy and ileostomy patients, respectively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concentration of other carotenoids in the chylomicron/TLR fraction</measure>
    <time_frame>24 hours</time_frame>
    <description>Changes in concentration of other carotenoids in the chylomicron/TLR fraction (area under the curve, AUC) 24 hours post first intervention meal in each intervention periods.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum concentration of other carotenoids</measure>
    <time_frame>15 days</time_frame>
    <description>Difference in serum concentration of other carotenoids between baseline and the end of each intervention period.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum concentration of other fat-soluble vitamins</measure>
    <time_frame>15 days</time_frame>
    <description>Difference in serum concentration of other vitamins (A, E; D, K) between baseline and the end of each intervention period.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in metabolic markers</measure>
    <time_frame>24 hours</time_frame>
    <description>Changes in overall metabolic markers from urine 24 hours postprandial</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in metabolic markers</measure>
    <time_frame>24 hours</time_frame>
    <description>Changes in overall metabolic markers in the chylomicron/TLR fraction 24 hours postprandial</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in metabolic markers</measure>
    <time_frame>15 days</time_frame>
    <description>Changes in overall metabolic markers in serum at the end of each intervention period.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of optical density of the macula lutea</measure>
    <time_frame>Baseline</time_frame>
    <description>Level of optical density in the macula lutea (MPOD), in the spectra where xanthophyll pigment is absorbing light.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Ileostomy; Functional Disturbance</condition>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Spinach - Whole leaf (10 mg lutein)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1-2: Group given whole leaf as first intervention Whole leaf spinach (10 mg lutein) given every second day for a 15 days period.
Followed by:
Minced spinach (10 mg lutein) given every second day for a 15 days period.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Spinach - Minced (10 mg lutein)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2-1: Group given minced spinach as first intervention Minced spinach (10 mg lutein) given every second day for a 15 days period.
Followed by:
Whole leaf spinach (10 mg lutein) given every second day for a 15 days period.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Spinach - Whole leaf (10 mg lutein)</intervention_name>
    <description>Identical spinach meals processed in two different ways by Frigodan, served alone or together with habitual diet</description>
    <arm_group_label>Spinach - Whole leaf (10 mg lutein)</arm_group_label>
    <arm_group_label>Spinach - Minced (10 mg lutein)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Spinach - Minced (10 mg/lutein)</intervention_name>
    <description>Identical spinach meals processed in two different ways by Frigodan, served alone or together with habitual diet</description>
    <arm_group_label>Spinach - Whole leaf (10 mg lutein)</arm_group_label>
    <arm_group_label>Spinach - Minced (10 mg lutein)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        List of inclusion criteria:

          -  Healthy adults (18-80 years old)

          -  Body Mass Index (BMI) between 18,9-28

          -  Normal fasting blood glucose (BS) (1,9-5,6 mmol/L)

          -  Tolerates: Potatoes, rice, chicken, meat (non vegan/vegetarian).

        List of exclusion criteria:

          -  Intestinal diseases (among healthy controls), systemic infections, psychiatric
             disorders, metabolic diseases (incl. diabetes), and any clinical
             condition/circumstance which assessed by the study official makes the person unfit for
             participation in the trial.

          -  Patients diagnosed with short bowel syndrome (SBS).

          -  Chronic or frequent use of medication. Primarily consumption of drugs with known
             effect/side effects on fat absorption. Further, anticoagulants (Marevan) and systemic
             treatment with glucocorticoids.

          -  Have or have had a drug addiction

          -  Smokers

          -  Alcohol consumption beyond the recommended (7/14 units per week for women/men,
             respectively)

          -  Intake of vitamins or other supplements (3 months before the study and during the
             study) (healthy controls). Subjects from the patient group included only with stable
             intake of dietary supplements through the last 3 months.

          -  Sampling or donation of larger amount of blood e.g. as blood donors or to other
             scientific experiments from 3 months before the study until its completion.

          -  allergy or intolerance to any of the foods included in the study.

          -  Women who are nursing, pregnant or planning pregnancy

          -  Not able to comply with the procedures protocol.

          -  Macular degeneration to a degree greeter than or equal to a surface area with one or
             more drusen larger than 125 microns in diameter in at least one eye.

          -  Cataracts, macular- or other ocular disease, preventing depiction of xanthophyll
             pigment.

        The following separate registered information was additionally recorded for short
        bowel/ileostomy patients:

          -  Time since operation (stable, &gt;1 year post operation)

          -  Type of disease/background for operation

          -  Intestinal anatomy (inclusive length and type of residual intestine)

          -  Type and doses of vitamin and other types of supplementation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lars O Dragsted, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Copenhagen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rigshospitalet, Department of Gastroenterology, CA-2121</name>
      <address>
        <city>Copenhagen Ã˜</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Nutrition, Exercise and Sports, University of Copenhagen</name>
      <address>
        <city>Frederiksberg C</city>
        <zip>1958</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 17, 2015</study_first_submitted>
  <study_first_submitted_qc>May 18, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 21, 2015</study_first_posted>
  <last_update_submitted>March 21, 2016</last_update_submitted>
  <last_update_submitted_qc>March 21, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Copenhagen</investigator_affiliation>
    <investigator_full_name>Professor Lars Ove Dragsted</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pathologic Processes</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carotenoids</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

